GSK hails "major step forward" after "positive" hepatitis drug results
(Alliance News) - GSK PLC on Thursday reported "positive" phase 3 trial data for its hepatitis B treatment, Bepirovirsen, which it said could "redefine" treatment for the disease. Read More